GDF15 and intestinal polyp: Its activation has been linked with a reduced propensity to develop intestinal polyps and tumors in mice (reviewed in [48]), which, combined with its expression being regulated by NSAIDs, evoke an interest in NAG1/GDF-15/MIC-1 as a chemopreventive agent.